PRDX3 and breast carcinoma: A recent study indicates that activation of the extracellular signal-regulated kinase (ERK) signaling may also result in the MMP1 transcriptional activation in the peroxiredoxin 3 (PRDX3)-overexpressed breast cancer cells [52].